CALQUENCE — ASTRAZENECA, approved 2026-02-19 (NDA210259).
6,999 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.